Welcome to the 25th Annual Market Access Summit, Canada’s premier gathering for industry, policy, and patient leaders to address the most pressing hurdles in healthcare delivery. Here’s what’s in store:
- Solve Complex Reimbursement Hurdles: Assess the transition from traditional rebates to outcomes-based models and the strategic necessity of a coordinated dual-market access approach in the Pharmacare era.
- Utilize Modern Evidence Currencies: Evaluate how Generative AI and Real-World Evidence are evolving into core requirements for HTA reassessment and long-term funding.
- Strengthen Strategic Stakeholder Alignment: Build a direct dialogue with key decision-makers to bridge the gap between manufacturer value propositions and provincial budget realities.
- Streamline High-Complexity Market Entry: Explore high-level tactics for the new FAST oncology pathway and specialized regulatory models for rare diseases and pediatric innovation.
- Align Regional and Federal Mandates: Gain early signals on how federal funding is reshaping provincial drug budgets and pipeline prioritization.























